title: Neurotoxic and pharmacokinetic responses to trichloroethylene as a function of exposure scenario.
abstract: Strategies are needed for assessing the risks of exposures to airborne toxicants that vary over concentrations and durations. The goal of this project was to describe the relationship between the concentration and duration of exposure to inhaled trichloroethylene (TCE), a representative volatile organic chemical, tissue dose as predicted by a physiologically based pharmacokinetic model, and neurotoxicity. Three measures of neurotoxicity were studied: hearing loss, signal detection behavior, and visual function. The null hypothesis was that exposure scenarios having an equivalent product of concentration and duration would produce equal toxic effects, according to the classic linear form of Haber's Rule ((italic)C(/italic) times t = k), where C represents the concentration, t, the time (duration) of exposure, and k, a constant toxic effect. All experiments used adult male, Long-Evans rats. Acute and repeated exposure to TCE increased hearing thresholds, and acute exposure to TCE impaired signal detection behavior and visual function. Examination of all three measures of neurotoxicity showed that if Haber's Rule were used to predict outcomes across exposure durations, the risk would be overestimated when extrapolating from shorter to longer duration exposures, and underestimated when extrapolating from longer to shorter duration exposures. For the acute effects of TCE on behavior and visual function, the estimated concentration of TCE in blood at the time of testing correlated well with outcomes, whereas cumulative exposure, measured as the area under the blood TCE concentration curve, did not. We conclude that models incorporating dosimetry can account for differing exposure scenarios and will therefore improve risk assessments over models considering only parameters of external exposure.
authors.affiliation: Neurotoxicology Division, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711, USA. william@epa.gov
authors.forename: W K
authors.initials: WK
authors.lastname: Boyes
authors.forename: P J
authors.initials: PJ
authors.lastname: Bushnell
authors.forename: K M
authors.initials: KM
authors.lastname: Crofton
authors.forename: M
authors.initials: M
authors.lastname: Evans
authors.forename: J E
authors.initials: JE
authors.lastname: Simmons
mesh_terms: D000818:Animals; D001921:Brain / Q000378:metabolism; D004781:Environmental Exposure; D006801:Humans; D009420:Nervous System / Q000187:drug effects / Q000378:metabolism; D009498:Neurotoxins / Q000493:pharmacokinetics* / Q000494:pharmacology*; D009994:Osmolar Concentration; D013997:Time Factors; D014241:Trichloroethylene / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology*
chemical_list: D009498:Neurotoxins; D014241:Trichloroethylene